Change in T cell cytokines and Tregs as markers of HBV reactivation in patients with hepatocellular carcinoma

被引：0
|
作者：
Lee, Sung Won [1 ,2 ]
Lee, Hae Lim [1 ,2 ]
Yoo, Sun Hong [1 ,2 ]
Kwon, Jung Hyun [1 ,2 ]
Nam, Soon woo [1 ,2 ]
Jang, Jeong Won [1 ,2 ]
机构：
[1] Catholic Univ Korea, Div Hepatol, Dept Internal Med, Coll Med, Seoul, South Korea
[2] Catholic Univ, Liver Res Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1507
引用
收藏
页码：803A / 804A
页数：2
相关论文
共 50 条
  • [1] Effects of microwave ablation on T-cell subsets and cytokines of patients with hepatocellular carcinoma
    Zhang, Haiwen
    Hou, Xiaowei
    Cai, Hongjian
    Zhuang, Xingjun
    [J]. MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 2017, 26 (04) : 207 - 211
  • [2] Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma
    Jang, Jeong Won
    Kwon, Jung Hyun
    You, Chan Ran
    Kim, Jin Dong
    Woo, Hyun Young
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Chung, Kyu Won
    [J]. ANTIVIRAL THERAPY, 2011, 16 (07) : 969 - 977
  • [3] The Risk Factors of HBV Reactivation After Conformal Radiation Therapy in Patients With Hepatocellular Carcinoma
    Huang, W.
    Zhang, W.
    Fan, M.
    Zhang, J.
    Li, H.
    Li, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S368 - S368
  • [4] Personalized T Cell Therapy Against HBV Related Hepatocellular Carcinoma
    Tan, Anthony
    Krishnamoorthy, Thinesh Lee
    Yang, Ninghan
    Low, Diana
    Tham, Christine
    Khakpoor, Atefeh
    Felinska, Eleni
    Oei, Vincent
    Giri, Reshmi
    Ho, Zi Zong
    Tan, Hiang Keat
    Kumar, Rajneesh
    Hwang, William
    Guccione, Ernesto
    Chow, Wan-Cheng
    Bertoletti, Antonio
    [J]. HEPATOLOGY, 2018, 68 : 520A - 520A
  • [5] Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
    Lee, Pei-Chang
    Chao, Yee
    Chen, Ming-Huang
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [6] Factors associated with postoperative HBV reactivation in HBV related hepatocellular carcinoma patients with HBV-DNA levels less than the minimum
    Chen, Jie
    Bai, Tao
    Wang, Xiao-Bo
    Xie, Zhi-Bo
    Liu, Jun-Jie
    Zhang, Yu
    Wu, Fei-Xiang
    Li, Le-Qun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 4533 - 4538
  • [7] Safety and efficacy of HBV specific TCR-redirected T cell therapy in patients with HBV-related hepatocellular carcinoma
    Jin, J.
    Li, Y.
    Wang, F.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1797 - 1798
  • [8] THE INTERRELATIONSHIP BETWEEN HBV-MARKERS AND HIV ANTIBODIES IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    TSWANA, SA
    MOYO, SR
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1992, 37 (03) : 161 - 164
  • [9] FREQUENCY OF HEPATIC HBV-DNA IN PATIENTS WITH CIRRHOSIS AND HEPATOCELLULAR-CARCINOMA - RELATION TO SERUM HBV MARKERS
    WHITE, YS
    JOHNSON, PJ
    DAVISON, F
    WILLIAMS, R
    [J]. BRITISH JOURNAL OF CANCER, 1990, 61 (06) : 909 - 912
  • [10] Dynamics of regulatory T cells (Tregs) in patients with oral squamous cell carcinoma
    Aggarwal, Sadhna
    Sharma, Suresh C.
    Das, Satya N.
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) : 1103 - 1113
12345